Health Discovery Corp (HDVY)

[dollardaze]

From The DGX Conference Call Transcript:
(Shelly Gnall is from Goldman Sachs)
Shelley Gnall-Sazenski
Understood. And then just a quick one. I understand you've got a 4-gene urinalysis prostate cancer test under development. Can you give us any update on this test, where it is and whether it's expected to be an important test?

Kathleen Valentine

You threw me off with the name. 4G?

Shelley Gnall-Sazenski

The 4-gene.

Kathleen Valentine

Oh, the 4-gene. Okay, yes. It's still in development, Shelley. And while it's in development, we don't have anything to comment on yet. But we're pleased with the progress that it's making. And then when we get to a stage where we have something to disclose, we certainly will do so.

Shelley Gnall-Sazenski

Okay, great. Thanks, very much.